i have got a reply from Jane:
"The company expects to update the market soon on its SubB2M programs. As INOVIQ has stated in its milestones, it is appointing a CRO for its SubB2M ovarian and breast cancer programs. This is an important milestone in the SubB2M program to advance assay development, optimisation and future validation of the tests."
so definitely we will see the some updates soon.
i have got a reply from Jane:"The company expects to update the...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $62.30M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 56.5¢ | 56.0¢ | $4.443K | 7.893K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15446 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 380 | 1 |
View Market Depth
| Last trade - 15.42pm 23/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |